Oct 6 (Reuters) - Australian Pharmaceutical Industries Ltd API.AX
* Underlying npat guidance upgraded to $51m - 17% up on prior year
* CEO & MD succession and fy16 forecast update-api.ax
* CEO and Managing Director Stephen Roche to step down in february 2017
* Reported net debt at year end to be less than $30m
* Internal appointee, Richard Vincent to succeed Roche Source text for Eikon: ID:nASX3nc1pg Further company coverage: API.AX